Navigation Links
Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis

with substantial manufacturing costs and inconvenience for patients.

CYT007-TNFQb is a therapeutic vaccine in development for the treatment of psoriasis and other inflammatory conditions. It is designed to instruct the patient’s immune system to produce an anti- TNF-? antibody response. The induced antibodies aim to bind TNF-? in order to inhibit its inflammatory activity. That way, the subsequent inflammatory process should be slowed down and the deterioration of skin or other tissues reduced.

For further information please contact:
Cytos Biotechnology AG, Wagistrasse 25, CH-8952 Schlieren
Claudine Blaser, PhD
Director Corporate Communications
Tel.: +41 44 733 47 20
e-Mail: claudine.blaser@cytos.com
Webseite: www.cytos.com


About Cytos Biotechnology AG
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the ImmunodrugsTM. ImmunodrugsTM are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. ImmunodrugsTM are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its
ImmunodrugTM platform, Cytos Biotechnology has built a pipeline of different ImmunodrugTM candidates in various disease areas, of which 6 are currently in clinical development. The ImmunodrugTM candidates are developed both in-house and together with Novartis and Pfizer Animal Health. Founded in 1995 as a spin-off from the Swiss Federal Institute of Technology (ETH) in Zurich, the company is located in Schlieren (Zurich). Currently, the company has
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:9/1/2015)... Calif. , Sept. 1, 2015 ... Care Management (CCM) and Drug Adherence m Health ... help automate the process of non face-to-face monitoring ... "With this new release of our apps, doctors ... management services along with our ONCHIT certified Physician, ...
(Date:9/1/2015)... , Sept. 1, 2015 Within ... employees, SHL Group has rapidly reached 3,000 employees ... rapid growth in the injectable drug delivery market ... A global leader in the design and ... offers innovative designs, robust manufacturing capabilities, a lean ...
(Date:9/1/2015)... , Sept. 1, 2015 Egalet Corporation ... specialty pharmaceutical company focused on discovering, developing, and ... will be  presenting scientific data on SPRIX ® ... extended-release, oral morphine product candidate, and Egalet-002, an ... PainWeek 2015 to be held September ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2SHL Group Reaches Major Milestone of 3000 Employees 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
... /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ... announced today its preliminary unaudited sales range for the ... guidance for full year 2010. A conference call to ... be held on October 25, 2010 at 8:00 a.m. ...
... The National Community Pharmacists Association (NCPA) today announced ... President and CEO, heralding her as an ideal ... and lead it to new heights as an ... and the patients they serve. (Logo: ...
Cached Medicine Technology:Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 2Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 3Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 4NCPA Announces Kathleen Jaeger as CEO 2
(Date:9/1/2015)... ... September 01, 2015 , ... Zecurion, a leading developer of data ... new version of endpoint DLP developed specifically for Mac OS. , In June 2015, ... 100 IT and information security professionals had participated. The beta test done by the ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , ... facioscapulohumeral muscular dystrophy (FSHD), will be the beneficiary of a collection of fundraising events ... to raise awareness of the FSH Society and further FSHD research. , ...
(Date:9/1/2015)... San Diego, CA (PRWEB) , ... September 01, 2015 , ... ... farms are just a few of the topics to be discussed at Seedstock’s 4th ... for Nov. 3-4, 2015, at UC San Diego. , In addition to keynotes ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed ... on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Nurse Scholar-in Residence at the Institute of Medicine (IOM) of the National Academies. ... at Columbia University School of Nursing. A member of the Institute of Medicine ...
Breaking Medicine News(10 mins):Health News:Zecurion Announces Endpoint Security for Mac 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 2Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 3Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 4Health News:Experts in Urban and Local Food Systems Development to Address Seedstock Sustainable Agriculture Conference Nov. 3-4 Discounted ticket sales end Sept. 4 5Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2
... NEW YORK, July 1, 2009 Since the 1970s, there ... autism have difficulty in understanding speech in situations where there ... meeting of the International Multisensory Research Forum (June 29th ... York (CCNY), neuroscientists announced conclusive evidence to verify this fact. ...
... SEATTLE, July 2 iMedExchange, the fastest growing ... of VitalSigns , a wholly owned family ... updates and peer insight on issues that matter to physicians. ... helps physicians cut through the clutter by providing high-value postings ...
... , WellPoint is one of few in the industry providing ... July 2 WellPoint Inc.,s (NYSE: WLP ) ... the June edition of Value in Health, the journal of ... , WellPoint is one of few health care management companies ...
... 2 /PRNewswire/ -- Thomson Reuters is working with ... Health to support development of the CDC,s Harmful Algal Bloom-related ... system collects data on human and animal health and on ... , As part of the project, the National Center for ...
... ... & Dodig in 2008 secured four regionally and nationally ranked recoveries on behalf of ... ... The Philadelphia personal injury law firm of Feldman, Shepherd, Wohlgelernter, Tanner, Weinstock ...
... , WASHINGTON, July 2 A new organization, the American ... physicians a unified voice on issues that affect their relationship ... is health care reform; the organization will fight proposals for ... doctor-patient relationship. , , "If these proposals are ...
Cached Medicine News:Health News:Children with autism need to be taught in smaller groups, pilot study confirms 2Health News:iMedExchange Launches Health Policy Resource Center 2Health News:WellPoint's Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication 2Health News:WellPoint's Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication 3Health News:CDC's National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms 2Health News:Recoveries Secured by Philadelphia Personal Injury Law Firm Feldman Shepherd Rank among Top 50 in Pennsylvania and Top 100 in U.S. 2Health News:Recoveries Secured by Philadelphia Personal Injury Law Firm Feldman Shepherd Rank among Top 50 in Pennsylvania and Top 100 in U.S. 3Health News:American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients; Organizing Doctors to Oppose Government-Run Health Care 2
Inquire...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: